Artificial Intelligence driven Marketing Communications
Glaucoma Therapeutics Market Size, Share and Industry Analysis By Drug Class (Beta Blockers, Prostaglandins, Alpha Adrenergic Agonists, Carbonic Anhydrase Inhibitors, Combination Drugs), By Disease Indication (Open Angle Glaucoma, Angle Closure Glaucoma), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Regional Forecast, 2019 â€“ 2026.
Glaucoma Therapeutics Market2020 Global Industry Size, Growth, Share, Industry Trends and Regional Forecast to 2026 is comprehensive study on Global Glaucoma Therapeutics Market published by “Fortune Business Insights”. According to report the global Glaucoma Therapeutics market size is predicted to grow $ 10,091.0 Million by 2026, exhibiting a CAGR of 6.1% during the forecast period.
An Overview of the Impact of COVID-19 on Glaucoma Therapeutics Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Global Glaucoma Therapeutics Market Insights:
The global Glaucoma Therapeutics Market is likely to expand in the coming years due to the remarkable increase in glaucoma cases. Glaucoma has affected around 64 million people across the globe. Glaucoma is a disease that may affect the optic nerve and prevalence of any stage of glaucoma may result in partial or full blindness. The severity of glaucoma has led to an increased awareness among end users about ways to manage glaucoma and people have realized the importance of detecting and treating this disease at an early stage.
Glaucoma Therapeutics Industry Key Players Analyzed in Report Are:
Glaucoma Therapeutics Market Research report include Merck and Co., Inc., Novartis AG, Allergan plc, Bausch and Lomb Incorporated, Teva Pharmaceutical Industry, Aerie Pharmaceuticals Pfizer, Inc., and Inotek Pharmaceuticals.
Glaucoma Therapeutics Market Size, Share and Industry Analysis By Drug Class (Beta Blockers, Prostaglandins, Alpha Adrenergic Agonists, Carbonic Anhydrase Inhibitors, Combination Drugs), By Disease Indication (Open Angle Glaucoma, Angle Closure Glaucoma), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Regional Forecast, 2019 2026.
Among all drug types, prostaglandin analogues are likely to emerge as the most widely used product type. Prostaglandin analogues are mostly recommended for the first line therapy for glaucoma, owing to their high efficacy and clinical success in glaucoma therapeutics. Prostaglandin analogues accounted for almost 40.8% of the global market share in 2018 and this share is likely to increase in the coming years. Furthermore, rising uptake of prostaglandin analogues is likely to favor the growth of the global Glaucoma Therapeutics Market.
Increasing Prevalence of Glaucoma – A Major Driver for the Market in Asia Pacific
The global Glaucoma Therapeutics Market is dominated by North America. Improved healthcare infrastructure and efficient treatment options have favored the growth of the regional market. The Glaucoma Therapeutics Market in North America was valued at US$ 2,405.9 Mn in 2018 and it is likely to increase further in the coming years. The Glaucoma Therapeutics Market in Asia Pacific is likely to exhibit the highest CAGR in the forecast period. The fast-paced growth in Asia Pacific can be accounted to increasing cases of glaucoma in the region. Furthermore, active government participation and contribution from private organizations towards awareness and prevention of glaucoma are likely to augment the growth of the global Glaucoma Therapeutics Market and will continue to boost the market in the forthcoming years.
Highlights of the Report:
In-depth analysis of various insights, namely, Glaucoma Therapeutics Market trends, growth drivers, opportunities, and other related challenges.
Comprehensive details of key market players, their core competencies, and Glaucoma Therapeutics Market share.
The potency of suppliers and buyers to make better business decisions.
Lists out the market size in terms of volume.
Key questions answered in the report:
Table of Content:
Definitions and Assumptions
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune 411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Press Release Distributed by The Express Wire
To view the original version on The Express Wire visit Glaucoma Therapeutics Market Report 2020-2026